- Home
- ATR vs RGEN Comparison
ATR vs RGEN Comparison
Compare ATR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATR
- RGEN
- Stock Information
- Founded
- ATR 1992
- RGEN 1981
- Country
- ATR United States
- RGEN United States
- Employees
- ATR N/A
- RGEN N/A
- Industry
- ATR Plastic Products
- RGEN Medical/Dental Instruments
- Sector
- ATR Industrials
- RGEN Health Care
- Exchange
- ATR Nasdaq
- RGEN Nasdaq
- Market Cap
- ATR 9.3B
- RGEN 8.2B
- IPO Year
- ATR 1993
- RGEN N/A
- Fundamental
- Price
- ATR $116.25
- RGEN $142.30
- Analyst Decision
- ATR Buy
- RGEN Buy
- Analyst Count
- ATR 4
- RGEN 11
- Target Price
- ATR $167.50
- RGEN $170.90
- AVG Volume (30 Days)
- ATR 688.4K
- RGEN 1.0M
- Earning Date
- ATR 10-30-2025
- RGEN 10-28-2025
- Dividend Yield
- ATR 1.65%
- RGEN N/A
- EPS Growth
- ATR 24.99
- RGEN N/A
- EPS
- ATR 6.23
- RGEN 0.03
- Revenue
- ATR $3,662,533,000.00
- RGEN $707,890,000.00
- Revenue This Year
- ATR $4.30
- RGEN $17.50
- Revenue Next Year
- ATR $3.85
- RGEN $12.74
- P/E Ratio
- ATR $18.66
- RGEN $4,625.69
- Revenue Growth
- ATR 2.50
- RGEN 11.74
- 52 Week Low
- ATR $103.23
- RGEN $102.97
- 52 Week High
- ATR $178.03
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- ATR 25.93
- RGEN 44.45
- Support Level
- ATR $103.23
- RGEN $144.18
- Resistance Level
- ATR $116.96
- RGEN $151.25
- Average True Range (ATR)
- ATR 3.82
- RGEN 6.92
- MACD
- ATR -1.00
- RGEN -2.45
- Stochastic Oscillator
- ATR 44.95
- RGEN 9.42
About ATR AptarGroup Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.